In reduced uterine perfusion pressure (RUPP) rats, constituting an animal model of PE, supplementation with recombined SIRT1 protein alleviates PE manifestations, such as arterial hypertension, impaired placental angiogenesis, inflammatory response, and unfavorable pregnancy outcome [182]. Here, SIRT1 is linked to Hypertension.